Clinical Trial

ESP vs. EXORA Blocks for Analgesia in Laparoscopic Cholecystectomy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 3, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Patients undergoing laparoscopic cholecystectomy may experience moderate to severe postoperative pain. Effective postoperative analgesia enhances patient comfort and accelerates recovery. This study aims to compare the effects of Erector Spinae Plane (ESP) and External Oblique and Rectus Abdominis Plane (EXORA) blocks on postoperative pain management and analgesic consumption. The study is designed as a prospective, randomized, double-blind trial. Patients will be randomly assigned to groups, and both practitioners and evaluators will be blinded to group assignments. Our hypothesis is that the EXORA block will provide superior analgesia and require less analgesic consumption compared to the ESP block. The results will be assessed in terms of postoperative pain management, patient comfort, and additional analgesic requirements.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-27.
Trial Details
NCT Number NCT06900413
Lead Sponsor Aycan KURTARANGİL DOĞAN
Collaborators: Kutahya City Hospital
Conditions Erector Spinae Plane Block, Laparoscopic Cholecystectomy, Plane Block
Enrollment 56 participants
Start Date 2025-09
Primary Completion 2026-03 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-09-03